Review: transfusing incompatible RBCs—clinical aspects

1.Oberman HA. The history of transfusion medicine. In: Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG. Clinical practice of transfusion medicine. 3rd ed. New York: Churchill Livingstone, 1996:11-32.Search in Google Scholar

2.Hoffman R, Benz EJ Jr, Shattil SJ, et al., eds. Hematology basic principles and practice. 3rd ed. New York: Churchill Livingstone, 2000:367-75.Search in Google Scholar

3.Weiskopf RB, Kramer JH, Viele M, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000;92:1646-52.10.1097/00000542-200006000-00023Search in Google Scholar

4.Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348: 1055-60.10.1016/S0140-6736(96)04330-9Search in Google Scholar

5.Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-17.10.1056/NEJM1999021134006019971864Search in Google Scholar

6.Popovsky MA, Audet AM, Andrzejewski C. Transfusion-associated circulatory overload in orthopedic surgery patients: A multi-institutional study. Immunohematology 1996;12:87-9.10.21307/immunohematology-2019-753Search in Google Scholar

7.Popovsky MA. Circulatory overload. In: Popovsky MA, ed. Transfusion reactions. 2nd ed. Bethesda, MD: American Association of Blood Banks, 2001: 255-60.Search in Google Scholar

8.Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego: Academic Press, 2003.10.1016/B978-012586585-2/50007-XSearch in Google Scholar

9.International Committee for Standardization in Hematology. Recommended method for radioisotope red-cell survival studies. Br J Haematol 1980;45:659-66.10.1111/j.1365-2141.1980.tb07189.x7426443Search in Google Scholar

10.Mollison PL. Survival in vivo as a test for red cell compatibility. Haematologia 1972;6:139-45.Search in Google Scholar

11.Davenport RD. Hemolytic transfusion reactions. In: Popovsky MA, ed. Transfusion reactions. 2nd ed. Bethesda, MD: American Association of Blood Banks, 2001:1-44.Search in Google Scholar

12.Mechanisms of immune hemolysis. In: Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004:133-65.Search in Google Scholar

13.Langley GR, Owen JA, Padanyi R. The effect of blood transfusion on serum haptoglobin. Br J Haematol 1962;8:392-9.10.1111/j.1365-2141.1962.tb06543.x13928656Search in Google Scholar

14.The diagnosis of hemolytic anemias. In: Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004:33-60.Search in Google Scholar

15.Trainor LD, Solomon HM. Detecting myoglobin- uria:a low-tech analysis. Lab Med 1997;28:569-71.10.1093/labmed/28.9.569Search in Google Scholar

16.Jacobs DS, Garg U,Oxley DK. Chemistry. In: Jacobs DS, Oxley DK, DeMott WR, eds. Laboratory test handbook. 5th ed. Hudson, OH: Lexi-Comp, 75-302.Search in Google Scholar

17.Petz LD, Calhoun L, Shulman IA,et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382-92.10.1046/j.1537-2995.1997.37497265338.x9111275Search in Google Scholar

18.Cullis JO, Win N, Dudley JM, Kaye T. Posttransfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.Vox Sang 1995;69:355-7.10.1111/j.1423-0410.1995.tb00373.x8751307Search in Google Scholar

19.King KE, Shirley RS, Lankiewicz MW, Young- Ramsaran J, Ness PM. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients’ red cells. Transfusion 1997;37:376-81.10.1046/j.1537-2995.1997.37497265337.x9111274Search in Google Scholar

20.Petz LD, Calhoun L, Shulman IA, Johnson C,Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382-92.10.1046/j.1537-2995.1997.37497265338.x9111275Search in Google Scholar

21.Cullis JO, Win N, Dudley JM, Kaye T. Posttransfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.Vox Sang 1995;69:355-7.10.1111/j.1423-0410.1995.tb00373.x8751307Search in Google Scholar